{"id":26582,"date":"2014-06-20T08:56:39","date_gmt":"2014-06-20T12:56:39","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=26582"},"modified":"2014-06-20T08:56:39","modified_gmt":"2014-06-20T12:56:39","slug":"insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582","title":{"rendered":"Insmed Incorporated (NASDAQ:INSM): Receives The Breakthrough Therapy Designation"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 06\/20\/2014 (wallstreetpr) \u2013<b> Insmed Incorporated (NASDAQ:INSM) <\/b>has received the breakthrough designation to Arikayce. It is a form of treatment for the people suffering from nontuberculous mycobacterial lung disease. It is specifically meant for the adults who are treatment refractory. The biopharmaceutical company, Insmed, is into the development and commercializing of inhaled therapies aimed to cure serious lung diseases.<\/p>\n<p style=\"text-align: justify;\"><b>The Initial Reaction<\/b><\/p>\n<p style=\"text-align: justify;\">The breakthrough designation was given by the FDA. It was received by the Insmed Incorporated (NASDAQ:INSM) as it reported the positive data from the phase 2 clinical trial. There is a great need for the nontuberculous mycobacterium lung disease. Arikayce will undergo a clinical trial for the treatment for pseudomonas lung infections. The stock price posted gain of more than 40% after the news. There was high volume trading in the stock after the news that suggests that the higher prices are bound to stay.<\/p>\n<p style=\"text-align: justify;\"><b>The Great News<\/b><\/p>\n<p style=\"text-align: justify;\">Getting the designation from FDA is a great news as the company&#8217;s lead product Is Arikayce. It is an inhaled antibiotic treatment product. The patient gets the anti-infective directly to the place serious lung infections. Now with the designation, Insmed Incorporated (NASDAQ:INSM) can move ahead with the further development and review of Arikayce. It will also meet the FDA for the further regulatory proceedings. It will work out to find a pathway to acquire regulatory approval for Arikayce. The company has the right of potentially filing new drug applications on the basis of the early and mid-stage data. It will work as a base to get the approval.<\/p>\n<p style=\"text-align: justify;\">As of now, things are looking quite bright for the Insmed Incorporated (NASDAQ:INSM). It is not the time to sell the stock. Arikayce will be pushing for a new drug application soon. And if it happens, the chances of stock moving higher are quite high. Investors should wait for some consolidation before jumping to buy the stock.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 06\/20\/2014 (wallstreetpr) \u2013 Insmed Incorporated (NASDAQ:INSM) has received the breakthrough designation to Arikayce. It is a form of treatment for the people suffering [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":18467,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[7494,5668,2253],"stock_ticker":[],"class_list":["post-26582","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-insmed-incorporated","tag-insmed-incorporated-nasdaqinsm","tag-nasdaqinsm","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Insmed Incorporated (NASDAQ:INSM): Receives The Breakthrough Therapy Designation - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insmed Incorporated (NASDAQ:INSM): Receives The Breakthrough Therapy Designation - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 06\/20\/2014 (wallstreetpr) \u2013 Insmed Incorporated (NASDAQ:INSM) has received the breakthrough designation to Arikayce. It is a form of treatment for the people suffering [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-06-20T12:56:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Insmed-Incorporated.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"616\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Alan Masterson\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alan Masterson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582\"},\"author\":{\"name\":\"Alan Masterson\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90\"},\"headline\":\"Insmed Incorporated (NASDAQ:INSM): Receives The Breakthrough Therapy Designation\",\"datePublished\":\"2014-06-20T12:56:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582\"},\"wordCount\":325,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Insmed-Incorporated.png\",\"keywords\":[\"Insmed Incorporated\",\"Insmed Incorporated (NASDAQ:INSM)\",\"NASDAQ:INSM\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582\",\"name\":\"Insmed Incorporated (NASDAQ:INSM): Receives The Breakthrough Therapy Designation - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Insmed-Incorporated.png\",\"datePublished\":\"2014-06-20T12:56:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Insmed-Incorporated.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Insmed-Incorporated.png\",\"width\":1024,\"height\":616},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insmed Incorporated (NASDAQ:INSM): Receives The Breakthrough Therapy Designation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90\",\"name\":\"Alan Masterson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g\",\"caption\":\"Alan Masterson\"},\"description\":\"Alan has over 25 years of trading experience in the U.S. equity markets. He began his career in finance working on a program trading desk specializing in over-the-counter stocks. His career progressed from that point to his current position as senior trader on an institutional trading desk. In the evenings, Alan teaches economics at a local community college. He has contributed articles to various publications over the last six years, including feature articles for an economics magazine and various financial blogs. You may contact Alan via his email (alanmasterson@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/103338576216002376250).\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/alan-masterson\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insmed Incorporated (NASDAQ:INSM): Receives The Breakthrough Therapy Designation - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582","og_locale":"en_US","og_type":"article","og_title":"Insmed Incorporated (NASDAQ:INSM): Receives The Breakthrough Therapy Designation - Wall Street PR","og_description":"Boston, MA 06\/20\/2014 (wallstreetpr) \u2013 Insmed Incorporated (NASDAQ:INSM) has received the breakthrough designation to Arikayce. It is a form of treatment for the people suffering [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-06-20T12:56:39+00:00","og_image":[{"width":1024,"height":616,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Insmed-Incorporated.png","type":"image\/png"}],"author":"Alan Masterson","twitter_misc":{"Written by":"Alan Masterson","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582"},"author":{"name":"Alan Masterson","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90"},"headline":"Insmed Incorporated (NASDAQ:INSM): Receives The Breakthrough Therapy Designation","datePublished":"2014-06-20T12:56:39+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582"},"wordCount":325,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Insmed-Incorporated.png","keywords":["Insmed Incorporated","Insmed Incorporated (NASDAQ:INSM)","NASDAQ:INSM"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582","url":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582","name":"Insmed Incorporated (NASDAQ:INSM): Receives The Breakthrough Therapy Designation - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Insmed-Incorporated.png","datePublished":"2014-06-20T12:56:39+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Insmed-Incorporated.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Insmed-Incorporated.png","width":1024,"height":616},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/insmed-incorporated-nasdaqinsm-receives-the-breakthrough-therapy-designation-26582#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Insmed Incorporated (NASDAQ:INSM): Receives The Breakthrough Therapy Designation"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90","name":"Alan Masterson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g","caption":"Alan Masterson"},"description":"Alan has over 25 years of trading experience in the U.S. equity markets. He began his career in finance working on a program trading desk specializing in over-the-counter stocks. His career progressed from that point to his current position as senior trader on an institutional trading desk. In the evenings, Alan teaches economics at a local community college. He has contributed articles to various publications over the last six years, including feature articles for an economics magazine and various financial blogs. You may contact Alan via his email (alanmasterson@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/103338576216002376250).","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/alan-masterson"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/26582","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=26582"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/26582\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/18467"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=26582"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=26582"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=26582"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=26582"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}